A Study Of Prostate Cancer Messages Motivate Black Men To Screen

Overview

About this study

This study aims to address a gap in the literature by empirically examining the effects of reason-based versus narrative-based (testimonial) messaging on prostate cancer screening intentions among Black men, which significantly influence behavior. Additionally, the study will investigate how demographic factors along with the health and cultural beliefs of Black men affect these outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male

  • Age 40 or older

  • English-speaking

  • Have never taken a prostate cancer screening test (Prostate Specific Antigen (PSA) or Digital Rectal Exam (DRE)). 

 

Exclusion Criteria:

  • Significant cognitive or visual impairment affecting participation

  • Incapable of comprehending the English language.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/12/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Contact us for the latest status

Jacksonville, Fla.

Mayo Clinic principal investigator

Contact us for the latest status

Rochester, Minn.

Mayo Clinic principal investigator

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions